Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,787 | 19,893 | 31,834 | 31,242 | 50,768 |
| TOTAL | $35,040 | $21,652 | $32,916 | $31,862 | $52,398 |
| Non-Current Assets | |||||
| PPE Net | 106 | 169 | 224 | 285 | 345 |
| Other Non-Current Assets | 702 | 704 | 535 | 0 | 0 |
| TOTAL | $808 | $873 | $759 | $285 | $345 |
| Total Assets | $35,848 | $22,525 | $33,675 | $32,147 | $52,743 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,000 | 8,982 | 10,410 | 14,634 | 14,716 |
| Accounts payable and accrued liabilities | 3,526 | 3,452 | 5,003 | 6,513 | 9,520 |
| Accrued Expenses | 8,523 | 7,817 | 6,677 | 8,573 | 9,714 |
| TOTAL | $21,049 | $20,251 | $22,090 | $29,720 | $33,950 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 1,526 |
| Other Non-Current Liabilities | 25,171 | 0 | 0 | 0 | 0 |
| TOTAL | $25,171 | $N/A | $N/A | $N/A | $1,526 |
| Total Liabilities | $46,220 | $20,251 | $22,090 | $29,720 | $35,476 |
| Shareholders' Equity | |||||
| Common Shares | 191 | 179 | N/A | N/A | 131 |
| Retained earnings | -555,454 | -537,116 | N/A | N/A | -497,997 |
| Other shareholders' equity | 0 | 0 | 11,585 | 2,427 | 0 |
| TOTAL | $-10,372 | $2,274 | $11,585 | $2,427 | $17,267 |
| Total Liabilities And Equity | $35,848 | $22,525 | $33,675 | $32,147 | $52,743 |